Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System
Retrieved on:
Friday, June 3, 2022
Consensus, Ketoacidosis, Kidney, Hospital, Life, Continuous glucose monitor, Prenatal nutrition, Diabetic ketoacidosis, DKA, Food, JDRF, CGM, Interpretation, Blood, Part, FreeStyle, Utility, Method, Journal of Diabetes Science and Technology, Risk, Review, Technology, Clinical case definition, NYSE, Pivotal, Adoption, Incidence, Diagnosis, Ketone, Heart, SGLT, CKM, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Integration, Glucose, Medical device, Pharmaceutical industry, Frankincense, Fine chemical, Diabetes, Patient
"We're designing our glucose-ketone monitoring system with superior sensing technology that will pair with industry-leading insulin pumps to create a best-in-class solution.
Key Points:
- "We're designing our glucose-ketone monitoring system with superior sensing technology that will pair with industry-leading insulin pumps to create a best-in-class solution.
- Recent studies show continuous ketone monitoring (CKM) could help prevent DKA.3 With continuous monitoring, rising ketone levels can be detected early, as a warning of impending ketoacidosis, and inform care so that DKA does not develop.
- Abbott is already conducting clinical studies on the glucose-ketone monitoring system.
- Abbott plans to partner with leading insulin pump manufacturers to make the dual monitoring system interoperable with insulin delivery systems.